Firm targets 3D printing synthetic tissues, organs

April 17, 2014
Firm targets 3D printing synthetic tissues, organs
Prototype droplet network printer built by Oxford scientists. Credit: OU/G Villar

(Medical Xpress)—A University of Oxford spin-out, OxSyBio, will develop 3D printing techniques to produce tissue-like synthetic materials for wound healing and drug delivery. In the longer term the company aims to print synthetic tissues for organ repair or replacement. 

Isis Innovation, the University's research commercialisation company, announced today that OxSyBio has raised £1 million from IP Group plc, the developer of intellectual property based businesses, subject to the achievement of milestones. The new company will refine and advance the 3D droplet printing technology devised by Professor Hagan Bayley's group at Oxford University's Department of Chemistry. 

Professor Bayley's group has developed a technique to print synthetic tissue-like materials from thousands of tiny water droplets each coated in a thin film mimicking a living cell's external membrane, and studding these membranes with protein pores so they act like simplified cells. The group's research was featured on the cover page of Science in April 2013.

Professor Hagan Bayley said: 'We have been able to print networks of droplets through which electrical impulses can be transmitted in a manner similar to the way cells in the nervous system communicate: the signal moves rapidly and in a specific direction. We also aim to integrate printed tissue-like materials with living tissues, and to print materials that themselves contain living cells. 

The video will load shortly
Credit: Oxford University

'Our long-term goal is to develop a synthetic-tissue printer that a surgeon can use in the operating theatre. In ten years' time, the use of pieces of synthetic tissue will be commonplace. The fabrication of complex synthetic organs is a more distant prospect.

'I am delighted to be working with Isis and IP Group to accelerate the development of our new company, OxSyBio. Our goal is to establish ourselves at the frontline of regenerative medicine.'

Tom Hockaday, managing director of Isis Innovation, said: 'This is the type of technology where science fiction can become science fact and Isis is proud to have been involved in creating a company around Professor Bayley's vision.'

Alan Aubrey, Chief Executive Officer of IP Group, said: 'Synthetic biology and regenerative medicine will be central to the development of healthcare in the 21st century and IP Group is pleased to support OxSyBio as it seeks to develop products that will help to realise the potential of these exciting and growing areas.' 

Explore further: New technology allows vital signs to be checked via webcam

Related Stories

3-D printer builds synthetic tissues

April 4, 2013

A custom-built programmable 3D printer can create materials with several of the properties of living tissues, Oxford University scientists have demonstrated.

Developing natural-looking, 3D-printed skin

November 27, 2013

Researchers at the University of Liverpool are developing synthetic skin that can be produced on a 3D printer and matched to a person based on their age, gender and ethnic group.

An essential step toward printing living tissues

February 19, 2014

A new bioprinting method developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard School of Engineering and Applied Sciences (SEAS) creates intricately patterned 3D tissue ...

Bioprinting new organs

April 3, 2014

With the new 3D Bioprinter, the research group of Professor Paul Gatenholm at the Department of Chemical and Biological Engineering exploits new possibilities of tissue engineering and organ regeneration.

Making 'bucky-balls' in spin-out's sights

April 16, 2014

(Phys.org) —A new Oxford spin-out firm is targeting the difficult challenge of manufacturing fullerenes, known as 'bucky-balls' because of their spherical shape, a type of carbon nanomaterial which, like graphene and carbon ...

Recommended for you

New avenue for understanding cause of common diseases

August 25, 2016

A ground-breaking Auckland study could lead to discoveries about many common diseases such as diabetes, cancer and dementia. The new finding could also illuminate the broader role of the enigmatic mitochondria in human development.

Basic research fuels advanced discovery

August 26, 2016

Clinical trials and translational medicine have certainly given people hope and rapid pathways to cures for some of mankind's most troublesome diseases, but now is not the time to overlook the power of basic research, says ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.